Purple Biotech Stock Price History
| PPBT Stock | USD 2.73 0.03 1.11% |
Below is the normalized historical share price chart for Purple Biotech extending back to November 20, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Purple Biotech stands at 2.73, as last reported on the 15th of March 2025, with the highest price reaching 2.78 and the lowest price hitting 2.66 during the day.
If you're considering investing in Purple Stock, it is important to understand the factors that can impact its price. Purple Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11 % return per unit of risk over the last 3 months. Purple Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Purple Biotech's Risk Adjusted Performance of (0.13), variance of 20.01, and Coefficient Of Variation of (622.94) to confirm the risk estimate we provide.
At this time, Purple Biotech's Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 160.8 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 28.3 M in 2025. . Price Earnings To Growth Ratio is likely to gain to 38.19 in 2025, whereas Price To Sales Ratio is likely to drop 84.89 in 2025. Purple Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of November 2015 | 200 Day MA 5.8228 | 50 Day MA 3.3269 | Beta 0.29 |
Purple |
Sharpe Ratio = -0.1119
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PPBT |
Estimated Market Risk
| 4.32 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.48 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Purple Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Purple Biotech by adding Purple Biotech to a well-diversified portfolio.
Price Book 0.2175 | Enterprise Value Ebitda (0.15) | Price Sales 58.0756 | Shares Float 1.7 M | Wall Street Target Price 33 |
Purple Biotech Stock Price History Chart
There are several ways to analyze Purple Stock price data. The simplest method is using a basic Purple candlestick price chart, which shows Purple Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 31, 2024 | 4.69 |
| Lowest Price | March 11, 2025 | 2.65 |
Purple Biotech March 15, 2025 Stock Price Synopsis
Various analyses of Purple Biotech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Purple Stock. It can be used to describe the percentage change in the price of Purple Biotech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Purple Stock.| Purple Biotech Price Action Indicator | 0.02 | |
| Purple Biotech Price Daily Balance Of Power | 0.25 | |
| Purple Biotech Price Rate Of Daily Change | 1.01 |
Purple Biotech March 15, 2025 Stock Price Analysis
Purple Stock Price History Data
The price series of Purple Biotech for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 has a statistical range of 2.04 with a coefficient of variation of 15.69. The price distribution for the period has arithmetic mean of 3.48. The median price for the last 90 days is 3.41. The company completed stock split (1:20) on 17th of September 2024. Purple Biotech had dividends distributed to its stock-holders on 2020-08-21.| Open | High | Low | Close | Volume | ||
03/15/2025 | 2.66 | 2.78 | 2.66 | 2.73 | ||
| 03/14/2025 | 2.66 | 2.78 | 2.66 | 2.73 | 9,209 | |
| 03/13/2025 | 2.78 | 2.78 | 2.68 | 2.70 | 3,003 | |
| 03/12/2025 | 2.73 | 2.78 | 2.65 | 2.73 | 12,400 | |
| 03/11/2025 | 2.76 | 2.76 | 2.64 | 2.65 | 10,571 | |
| 03/10/2025 | 2.81 | 2.84 | 2.65 | 2.72 | 15,917 | |
| 03/07/2025 | 2.77 | 2.89 | 2.77 | 2.81 | 4,106 | |
| 03/06/2025 | 2.88 | 2.94 | 2.76 | 2.94 | 7,203 | |
| 03/05/2025 | 2.90 | 3.00 | 2.69 | 2.89 | 48,229 | |
| 03/04/2025 | 2.80 | 2.83 | 2.61 | 2.77 | 12,719 | |
| 03/03/2025 | 3.00 | 3.00 | 2.78 | 2.82 | 17,480 | |
| 02/28/2025 | 2.83 | 2.98 | 2.69 | 2.98 | 15,261 | |
| 02/27/2025 | 2.97 | 2.97 | 2.85 | 2.85 | 6,646 | |
| 02/26/2025 | 2.88 | 3.07 | 2.84 | 3.05 | 21,541 | |
| 02/25/2025 | 3.01 | 3.15 | 2.84 | 2.94 | 13,721 | |
| 02/24/2025 | 3.06 | 3.12 | 2.90 | 3.06 | 25,220 | |
| 02/21/2025 | 3.23 | 3.33 | 3.07 | 3.17 | 6,681 | |
| 02/20/2025 | 3.32 | 3.32 | 3.20 | 3.25 | 7,346 | |
| 02/19/2025 | 3.40 | 3.48 | 3.20 | 3.30 | 33,905 | |
| 02/18/2025 | 3.40 | 3.40 | 3.15 | 3.22 | 39,913 | |
| 02/14/2025 | 3.11 | 3.17 | 3.01 | 3.10 | 13,554 | |
| 02/13/2025 | 3.07 | 3.20 | 3.07 | 3.19 | 17,849 | |
| 02/12/2025 | 3.07 | 3.07 | 2.99 | 2.99 | 9,126 | |
| 02/11/2025 | 2.99 | 3.18 | 2.90 | 3.08 | 19,124 | |
| 02/10/2025 | 3.19 | 3.20 | 2.95 | 3.11 | 15,831 | |
| 02/07/2025 | 3.28 | 3.28 | 2.83 | 3.00 | 33,717 | |
| 02/06/2025 | 3.20 | 3.37 | 3.12 | 3.28 | 16,575 | |
| 02/05/2025 | 3.19 | 3.32 | 3.15 | 3.30 | 12,040 | |
| 02/04/2025 | 3.17 | 3.20 | 3.06 | 3.18 | 11,540 | |
| 02/03/2025 | 3.33 | 3.33 | 3.11 | 3.16 | 52,478 | |
| 01/31/2025 | 3.32 | 3.32 | 3.08 | 3.25 | 23,832 | |
| 01/30/2025 | 3.39 | 3.40 | 3.10 | 3.26 | 21,238 | |
| 01/29/2025 | 3.46 | 3.46 | 3.28 | 3.36 | 8,578 | |
| 01/28/2025 | 3.43 | 3.47 | 3.32 | 3.41 | 48,955 | |
| 01/27/2025 | 3.60 | 3.60 | 3.36 | 3.40 | 18,919 | |
| 01/24/2025 | 3.51 | 3.85 | 3.40 | 3.66 | 52,136 | |
| 01/23/2025 | 3.46 | 3.86 | 3.38 | 3.60 | 50,026 | |
| 01/22/2025 | 3.52 | 3.56 | 3.40 | 3.46 | 40,202 | |
| 01/21/2025 | 3.58 | 3.69 | 3.43 | 3.54 | 45,783 | |
| 01/17/2025 | 3.75 | 3.87 | 3.52 | 3.54 | 63,906 | |
| 01/16/2025 | 3.70 | 3.72 | 3.49 | 3.72 | 97,455 | |
| 01/15/2025 | 3.69 | 3.69 | 3.46 | 3.64 | 31,835 | |
| 01/14/2025 | 3.69 | 3.87 | 3.53 | 3.62 | 45,314 | |
| 01/13/2025 | 3.91 | 3.91 | 3.67 | 3.78 | 18,356 | |
| 01/10/2025 | 3.80 | 3.97 | 3.69 | 3.89 | 67,233 | |
| 01/08/2025 | 4.04 | 4.13 | 3.78 | 3.78 | 53,010 | |
| 01/07/2025 | 4.42 | 4.42 | 4.00 | 4.19 | 82,878 | |
| 01/06/2025 | 4.35 | 4.55 | 4.30 | 4.49 | 60,825 | |
| 01/03/2025 | 4.52 | 4.71 | 4.41 | 4.51 | 50,282 | |
| 01/02/2025 | 4.95 | 4.95 | 4.28 | 4.59 | 140,706 | |
| 12/31/2024 | 4.19 | 5.20 | 4.19 | 4.69 | 266,810 | |
| 12/30/2024 | 4.17 | 4.49 | 4.05 | 4.29 | 153,010 | |
| 12/27/2024 | 4.30 | 4.98 | 3.94 | 4.36 | 397,297 | |
| 12/26/2024 | 3.79 | 4.40 | 3.70 | 4.33 | 102,841 | |
| 12/24/2024 | 3.95 | 4.01 | 3.64 | 3.82 | 90,682 | |
| 12/23/2024 | 3.39 | 3.97 | 3.18 | 3.70 | 141,040 | |
| 12/20/2024 | 3.40 | 3.49 | 3.31 | 3.42 | 112,086 | |
| 12/19/2024 | 3.55 | 3.66 | 3.33 | 3.45 | 205,334 | |
| 12/18/2024 | 3.85 | 4.01 | 3.56 | 3.61 | 158,600 | |
| 12/17/2024 | 3.94 | 4.10 | 3.80 | 3.92 | 108,773 | |
| 12/16/2024 | 3.85 | 4.22 | 3.78 | 3.88 | 156,487 |
About Purple Biotech Stock history
Purple Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Purple is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Purple Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Purple Biotech stock prices may prove useful in developing a viable investing in Purple Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 339.1 M | 356 M | |
| Net Loss | -19.5 M | -20.5 M |
Purple Biotech Quarterly Net Working Capital |
|
Purple Biotech Stock Technical Analysis
Purple Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Purple Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Purple Biotech's price direction in advance. Along with the technical and fundamental analysis of Purple Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Purple to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.63) | |||
| Total Risk Alpha | (0.17) | |||
| Treynor Ratio | (0.85) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.